I know it has been a long time since we've opened the room,..
I have been busy in life, work and everything now this Friday, the room is going
to be open and everyone please try to make it.
I really miss talking to you guys :)
Try to come up with some hot topics that we can talk about :)
Talk to you soon guys,
sweet
Thursday, March 26, 2009
Wednesday, March 18, 2009
R.I.P Haregewoin Teferra
I heard the bad news today, humantirean Haregwoin Tefferra, a mother of many orphan childern, passed away in her home in Ethiopia. As I always do, I reguraly follow up Melissa Fay Greene's Occasional blog. And today when I checked Melissa Fay'S Occasional Blog, I leared the bad news. Melissa stated on her blog that "She felt sick, called for a friend, and died in her bed. I have no more details at this time. I will post here as I learn more."
I remember how the first time I found out about Haregwoin Teferra, I was browsing around and I found this inspiring site/story about Haregewoin Teferra and Melissa Fay Greene herslef. Melissa Fay adopted five kids from Ethiopia and other countries as well. You may check the site and you would love what you see and a beatufil big family. You can even see how the kids adapted to the new environment and grow up fast. They all look so cute :)
I want to convey my deepest condolences to Hargewoin Teferra's family, friends and to all the orphan childern that she has been taking care off. May her soul rest in peace.
I remember how the first time I found out about Haregwoin Teferra, I was browsing around and I found this inspiring site/story about Haregewoin Teferra and Melissa Fay Greene herslef. Melissa Fay adopted five kids from Ethiopia and other countries as well. You may check the site and you would love what you see and a beatufil big family. You can even see how the kids adapted to the new environment and grow up fast. They all look so cute :)
I want to convey my deepest condolences to Hargewoin Teferra's family, friends and to all the orphan childern that she has been taking care off. May her soul rest in peace.
Thursday, March 5, 2009
BREAKING the SILENCE: Lifting the Stigma of AIDS in Ethiopia (Amharic version) (2006)
BREAKING the SILENCE: Lifting the Stigma of AIDS in Ethiopia (Amharic version) (2006)
STEPPING FORWARD: Men Teaching and Learning about HIV/AIDS (Amharic version)(2006)
STEPPING FORWARD: Men Teaching and Learning about HIV/AIDS (Amharic version)(2006)
Man appears free of HIV after stem cell transplant
(CNN) updated 4:51 p.m. EST, Wed February 11, 2009
A 42-year-old HIV patient with leukemia appears to have no detectable HIV in his blood and no symptoms after a stem cell transplant from a donor carrying a gene mutation that confers natural resistance to the virus that causes AIDS, according to a report published Wednesday in the New England Journal of Medicine.
“The patient is fine,” said Dr. Gero Hutter of Charite Universitatsmedizin Berlin in Germany. “Today, two years after his transplantation, he is still without any signs of HIV disease and without antiretroviral medication.”
The case was first reported in November, and the new report is the first official publication of the case in a medical journal. Hutter and a team of medical professionals performed the stem cell transplant on the patient, an American living in Germany, to treat the man’s leukemia, not the HIV itself.
However, the team deliberately chose a compatible donor who has a naturally occurring gene mutation that confers resistance to HIV. The mutation cripples a receptor known as CCR5, which is normally found on the surface of T cells, the type of immune system cells attacked by HIV.
The mutation is known as CCR5 delta32 and is found in 1 percent to 3 percent of white populations of European descent.
HIV uses the CCR5 as a co-receptor (in addition to CD4 receptors) to latch on to and ultimately destroy immune system cells. Since the virus can’t gain a foothold on cells that lack CCR5, people who have the mutation have natural protection. (There are other, less common HIV strains that use different co-receptors.)
People who inherit one copy of CCR5 delta32 take longer to get sick or develop AIDS if infected with HIV. People with two copies (one from each parent) may not become infected at all. The stem cell donor had two copies.
While promising, the treatment is unlikely to help the vast majority of people infected with HIV, said Dr. Jay Levy, a professor at the University of California San Francisco, who wrote an editorial accompanying the study. A stem cell transplant is too extreme and too dangerous to be used as a routine treatment, he said.
“About a third of the people die [during such transplants], so it’s just too much of a risk,” Levy said. To perform a stem cell transplant, doctors intentionally destroy a patient’s immune system, leaving the patient vulnerable to infection, and then reintroduce a donor’s stem cells (which are from either bone marrow or blood) in an effort to establish a new, healthy immune system.
Levy also said it’s unlikely that the transplant truly cured the patient in this study. HIV can infect many other types of cells and may be hiding out in the patient’s body to resurface at a later time, he said.
“This type of virus can infect macrophages (another type of white blood cell that expresses CCR5) and other cells, like the brain cells, and it could live a lifetime. But if it can’t spread, you never see it– but it’s there and it could do some damage,” he said. “It’s not the kind of approach that you could say, ‘I’ve cured you.’ I’ve eliminated the virus from your body.” Health.com: 10 questions to ask a new partner before having sex
Before undergoing the transplant, the patient was also found to be infected with low levels of a type of HIV known as X4, which does not use the CCR5 receptor to infect cells. So it would seem that this virus would still be able to grow and damage immune cells in his body. However, following the transplant, signs of leukemia and HIV were absent.
“There is no really conclusive explanation why we didn’t observe any rebound of HIV,” Hutter said. “This finding is very surprising.”
Hutter noted that one year ago, the patient had a relapse of leukemia and a second transplant from the same donor. The patient experienced complications from the procedure, including temporary liver problems and kidney failure, but they were not unusual and may occur in HIV-negative patients, he said.
Researchers including Hutter agree that the technique should not be used to treat HIV alone. “Some people may say, ‘I want to do it,’” said Levy. A more logical — and potentially safer — approach would be to develop some type of CCR5-disabling gene therapy or treatment that could be directly injected into the body, said Levy.
Less invasive options to alter CCR5 could be on the horizon within the next five years, said Levy. “It’s definitely the wave of the future,” he said. “As we continue to follow this one patient, we will learn a lot.”
One drug that’s currently on the market that blocks CCR5 is called maraviroc (Selzentry). It was first approved in 2007 and is used in combination with other antiretroviral drugs.
A 42-year-old HIV patient with leukemia appears to have no detectable HIV in his blood and no symptoms after a stem cell transplant from a donor carrying a gene mutation that confers natural resistance to the virus that causes AIDS, according to a report published Wednesday in the New England Journal of Medicine.
“The patient is fine,” said Dr. Gero Hutter of Charite Universitatsmedizin Berlin in Germany. “Today, two years after his transplantation, he is still without any signs of HIV disease and without antiretroviral medication.”
The case was first reported in November, and the new report is the first official publication of the case in a medical journal. Hutter and a team of medical professionals performed the stem cell transplant on the patient, an American living in Germany, to treat the man’s leukemia, not the HIV itself.
However, the team deliberately chose a compatible donor who has a naturally occurring gene mutation that confers resistance to HIV. The mutation cripples a receptor known as CCR5, which is normally found on the surface of T cells, the type of immune system cells attacked by HIV.
The mutation is known as CCR5 delta32 and is found in 1 percent to 3 percent of white populations of European descent.
HIV uses the CCR5 as a co-receptor (in addition to CD4 receptors) to latch on to and ultimately destroy immune system cells. Since the virus can’t gain a foothold on cells that lack CCR5, people who have the mutation have natural protection. (There are other, less common HIV strains that use different co-receptors.)
People who inherit one copy of CCR5 delta32 take longer to get sick or develop AIDS if infected with HIV. People with two copies (one from each parent) may not become infected at all. The stem cell donor had two copies.
While promising, the treatment is unlikely to help the vast majority of people infected with HIV, said Dr. Jay Levy, a professor at the University of California San Francisco, who wrote an editorial accompanying the study. A stem cell transplant is too extreme and too dangerous to be used as a routine treatment, he said.
“About a third of the people die [during such transplants], so it’s just too much of a risk,” Levy said. To perform a stem cell transplant, doctors intentionally destroy a patient’s immune system, leaving the patient vulnerable to infection, and then reintroduce a donor’s stem cells (which are from either bone marrow or blood) in an effort to establish a new, healthy immune system.
Levy also said it’s unlikely that the transplant truly cured the patient in this study. HIV can infect many other types of cells and may be hiding out in the patient’s body to resurface at a later time, he said.
“This type of virus can infect macrophages (another type of white blood cell that expresses CCR5) and other cells, like the brain cells, and it could live a lifetime. But if it can’t spread, you never see it– but it’s there and it could do some damage,” he said. “It’s not the kind of approach that you could say, ‘I’ve cured you.’ I’ve eliminated the virus from your body.” Health.com: 10 questions to ask a new partner before having sex
Before undergoing the transplant, the patient was also found to be infected with low levels of a type of HIV known as X4, which does not use the CCR5 receptor to infect cells. So it would seem that this virus would still be able to grow and damage immune cells in his body. However, following the transplant, signs of leukemia and HIV were absent.
“There is no really conclusive explanation why we didn’t observe any rebound of HIV,” Hutter said. “This finding is very surprising.”
Hutter noted that one year ago, the patient had a relapse of leukemia and a second transplant from the same donor. The patient experienced complications from the procedure, including temporary liver problems and kidney failure, but they were not unusual and may occur in HIV-negative patients, he said.
Researchers including Hutter agree that the technique should not be used to treat HIV alone. “Some people may say, ‘I want to do it,’” said Levy. A more logical — and potentially safer — approach would be to develop some type of CCR5-disabling gene therapy or treatment that could be directly injected into the body, said Levy.
Less invasive options to alter CCR5 could be on the horizon within the next five years, said Levy. “It’s definitely the wave of the future,” he said. “As we continue to follow this one patient, we will learn a lot.”
One drug that’s currently on the market that blocks CCR5 is called maraviroc (Selzentry). It was first approved in 2007 and is used in combination with other antiretroviral drugs.
Monday, March 2, 2009
Gene Therapy Study Shows Method Is Safe, Somewhat Beneficial
February 22, 2009 on 10:20 pm | In Science and Medicine |
Gene Therapy Study Shows Method Is Safe, Somewhat Beneficial, Researchers Report
A study of gene therapy to treat HIV has shown that the treatment is safe and somewhat beneficial — a “major advance” in efforts to combat the virus — researchers said in a study published recently in the journal Nature Medicine, AFP/Google.com reports. According to the researchers, the study — which was headed by Ronald Mitsuyasu of the University of California-Los Angeles — confirms that this avenue of gene therapy in HIV research is a valid approach (AFP/Google.com, 2/15). The study involved 74 HIV-positive people, half of whom received blood stem cells that included a molecule, called OZ1, which is designed to block HIV from replicating by targeting two key proteins (BBC News, 2/16). The other half were given a placebo. The study aimed to determine whether the stem cells would survive the body’s immune system and if this would curb the replication of HIV. The researchers found that after 48 weeks, there was no statistical difference between the two groups. However, after 100 weeks, the group that received the RNA enzyme gene had higher levels of CD4+ T cells and low HIV viral loads. The study also showed that the new blood stem cells depleted over time — although DNA tests showing that the modified cells were present in 94% of the gene group at four weeks, this fell to 12% by week 48 and 7% by week 100. According to the researchers, the study’s results showed the treatment was “safe” and modestly effective. Mitsuyasu said that instead of putting the technique through to a Phase III trial, the team plans to modify the technique and introduce new tests on a smaller group of participants. He said the study “gives some hope” to the gene therapy approach as a treatment for HIV and other diseases, such as cancer, adding, “It’s a positive finding for the field and should move the field forward” (AFP/Google.com, 2/15).
Reaction
Mitsuyasu said that the treatment is “not yet as effective or as complete as current antiretroviral therapy in controlling HIV,” although the recent study “did show proof” that using a single gene in an HIV-positive patient’s own blood cells could reduce the spread of the virus. Jo Robinson of the HIV/AIDS organization Terrence Higgins Trust said, “Gene therapy is an exciting area which aims to create a one off treatment for HIV, avoiding the need for people to take daily medication,” adding that the therapy is in its “early days in research terms, so we’re a long way from something like this being on the market.” Robinson said that the new study “has shown some promising results, which definitely warrant further investigation.” Keith Alcorn of the U.K.-based HIV information service NAM added that although the study’s results are “very modest,” the researchers showed “enough of an effect for us to be hopeful that a gene therapy approach to HIV treatment might eventually deliver effective treatments for the disease” (BBC News, 2/16).
Kaiser Daily HIV/AIDS Report
Gene Therapy Study Shows Method Is Safe, Somewhat Beneficial, Researchers Report
A study of gene therapy to treat HIV has shown that the treatment is safe and somewhat beneficial — a “major advance” in efforts to combat the virus — researchers said in a study published recently in the journal Nature Medicine, AFP/Google.com reports. According to the researchers, the study — which was headed by Ronald Mitsuyasu of the University of California-Los Angeles — confirms that this avenue of gene therapy in HIV research is a valid approach (AFP/Google.com, 2/15). The study involved 74 HIV-positive people, half of whom received blood stem cells that included a molecule, called OZ1, which is designed to block HIV from replicating by targeting two key proteins (BBC News, 2/16). The other half were given a placebo. The study aimed to determine whether the stem cells would survive the body’s immune system and if this would curb the replication of HIV. The researchers found that after 48 weeks, there was no statistical difference between the two groups. However, after 100 weeks, the group that received the RNA enzyme gene had higher levels of CD4+ T cells and low HIV viral loads. The study also showed that the new blood stem cells depleted over time — although DNA tests showing that the modified cells were present in 94% of the gene group at four weeks, this fell to 12% by week 48 and 7% by week 100. According to the researchers, the study’s results showed the treatment was “safe” and modestly effective. Mitsuyasu said that instead of putting the technique through to a Phase III trial, the team plans to modify the technique and introduce new tests on a smaller group of participants. He said the study “gives some hope” to the gene therapy approach as a treatment for HIV and other diseases, such as cancer, adding, “It’s a positive finding for the field and should move the field forward” (AFP/Google.com, 2/15).
Reaction
Mitsuyasu said that the treatment is “not yet as effective or as complete as current antiretroviral therapy in controlling HIV,” although the recent study “did show proof” that using a single gene in an HIV-positive patient’s own blood cells could reduce the spread of the virus. Jo Robinson of the HIV/AIDS organization Terrence Higgins Trust said, “Gene therapy is an exciting area which aims to create a one off treatment for HIV, avoiding the need for people to take daily medication,” adding that the therapy is in its “early days in research terms, so we’re a long way from something like this being on the market.” Robinson said that the new study “has shown some promising results, which definitely warrant further investigation.” Keith Alcorn of the U.K.-based HIV information service NAM added that although the study’s results are “very modest,” the researchers showed “enough of an effect for us to be hopeful that a gene therapy approach to HIV treatment might eventually deliver effective treatments for the disease” (BBC News, 2/16).
Kaiser Daily HIV/AIDS Report
The Ride: Seven Days to end HIV/AIDS
Some of the riders share their stories of their HIV status and their personal reasons for joining The Ride. Watch the video
click here.
Living with HIV and AIDS
Watch the Video
Love Lessons: Perry, Part- 1
Love Lessons: Perry, Part- 2
Love Lessons: Perry, Part-3
Love Lessons: Perry, Part- 4
click here.
Living with HIV and AIDS
Watch the Video
Love Lessons: Perry, Part- 1
Love Lessons: Perry, Part- 2
Love Lessons: Perry, Part-3
Love Lessons: Perry, Part- 4
Thursday, February 26, 2009
Antiretroviral Therapy Highlights From CROI 2009
A Discussion With Joel Gallant, M.D., M.P.H.
By Bonnie Goldman
February 25, 2009
Hello and welcome. This is Bonnie Goldman, Editorial Director of TheBody.com. I'm here today with Dr. Joel Gallant. Dr. Gallant has been treating people with HIV since the beginning of the pandemic. He's also a leading HIV researcher and a professor at Johns Hopkins University School of Medicine in Baltimore, Md.
Read More...
Source:
The Body
By Bonnie Goldman
February 25, 2009
Hello and welcome. This is Bonnie Goldman, Editorial Director of TheBody.com. I'm here today with Dr. Joel Gallant. Dr. Gallant has been treating people with HIV since the beginning of the pandemic. He's also a leading HIV researcher and a professor at Johns Hopkins University School of Medicine in Baltimore, Md.
Read More...
Source:
The Body
Overall Estimate of People Living With HIV in the U.S. Grows: 21 Percent, Mostly Minorities, Undiagnosed
An Interview With Michael Campsmith, D.D.S., M.P.H.By Bonnie Goldman
My name is Michael Campsmith, and I'm an epidemiologist with the Centers for Disease Control and Prevention [CDC] in Atlanta. My group is the HIV incidence and case surveillance branch. I'm presenting at the CROI conference on an analysis of the prevalence of HIV in the United States at the end of 2006, and we're focusing on the percent of persons who are undiagnosed -- who have HIV infection but are undiagnosed.1
If we don't know they're diagnosed, what's the process the CDC uses to arrive at these numbers?
All areas [in the U.S.] are funded to collect surveillance data. They do that at the local level and send that data without personal identifiers to the CDC. We compile national data, and then there's a statistical modeling procedure.
Read more.
Listen to Audio....
My name is Michael Campsmith, and I'm an epidemiologist with the Centers for Disease Control and Prevention [CDC] in Atlanta. My group is the HIV incidence and case surveillance branch. I'm presenting at the CROI conference on an analysis of the prevalence of HIV in the United States at the end of 2006, and we're focusing on the percent of persons who are undiagnosed -- who have HIV infection but are undiagnosed.1
If we don't know they're diagnosed, what's the process the CDC uses to arrive at these numbers?
All areas [in the U.S.] are funded to collect surveillance data. They do that at the local level and send that data without personal identifiers to the CDC. We compile national data, and then there's a statistical modeling procedure.
Read more.
Listen to Audio....
Wealthy men give women more orgasms
From The Sunday Times
January 18, 2009
Jonathan Leake, Science and Environment Editor
Scientists have found that the pleasure women get from making love is directly linked to the size of their partner’s bank balance.
They found that the wealthier a man is, the more frequently his partner has orgasms.
“Women’s orgasm frequency increases with the income of their partner,” said Dr Thomas Pollet, the Newcastle University psychologist behind the research.
He believes the phenomenon is an “evolutionary adaptation” that is hard-wired into women, driving them to select men on the basis of their perceived quality.
The study is certain to prove controversial, suggesting that women are inherently programmed to be gold-diggers.
However, it fits into a wider body of research known as evolutionary psychology which suggests that both men and women are genetically predisposed to ruthlessly exploit each other to achieve the best chances of survival for their genes.
The female orgasm is the focus of much research because it appears to have no reproductive purpose. Women can become pregnant whatever their pleasure levels.
Pollet, and Professor Daniel Nettle, his co-author, believed, however, that the female orgasm is an evolutionary adaptation that drives women to choose and retain high-quality partners.
He and Nettle tested that idea using data gathered in one of the world’s biggest lifestyle studies. The Chinese Health and Family Life Survey targeted 5,000 people across China for in-depth interviews about their personal lives, including questions about their sex lives, income and other factors. Among these were 1,534 women with male partners whose data was the basis for the study.
They found that 121 of these women always had orgasms during sex, while 408 more had them “often”. Another 762 “sometimes” orgasmed while 243 had them rarely or never. Such figures are similar to those for western countries.
There were of course, several factors involved in such differences but, said Pollet, money was one of the main ones.
He said: “Increasing partner income had a highly positive effect on women’s self-reported frequency of orgasm. More desirable mates cause women to experience more orgasms.”
This is not an effect limited to Chinese women. Previous research in Germany and America has looked at attributes such as body symmetry and attractiveness, finding that these are also linked with orgasm frequency. Money, however, seems even more important.
David Buss, professor of psychology at the University of Texas, Austin, who raised this question in his book The Evolution of Desire believes female orgasms have several possible purposes.
“They could promote emotional bonding with a high-quality male or they could serve as a signal that women are highly sexually satisfied, and hence unlikely to seek sex with other men,” he said. “What those orgasms are saying is ‘I'm extremely loyal, so you should invest in me and my children’."
Source:
TIMESONLINE
January 18, 2009
Jonathan Leake, Science and Environment Editor
Scientists have found that the pleasure women get from making love is directly linked to the size of their partner’s bank balance.
They found that the wealthier a man is, the more frequently his partner has orgasms.
“Women’s orgasm frequency increases with the income of their partner,” said Dr Thomas Pollet, the Newcastle University psychologist behind the research.
He believes the phenomenon is an “evolutionary adaptation” that is hard-wired into women, driving them to select men on the basis of their perceived quality.
The study is certain to prove controversial, suggesting that women are inherently programmed to be gold-diggers.
However, it fits into a wider body of research known as evolutionary psychology which suggests that both men and women are genetically predisposed to ruthlessly exploit each other to achieve the best chances of survival for their genes.
The female orgasm is the focus of much research because it appears to have no reproductive purpose. Women can become pregnant whatever their pleasure levels.
Pollet, and Professor Daniel Nettle, his co-author, believed, however, that the female orgasm is an evolutionary adaptation that drives women to choose and retain high-quality partners.
He and Nettle tested that idea using data gathered in one of the world’s biggest lifestyle studies. The Chinese Health and Family Life Survey targeted 5,000 people across China for in-depth interviews about their personal lives, including questions about their sex lives, income and other factors. Among these were 1,534 women with male partners whose data was the basis for the study.
They found that 121 of these women always had orgasms during sex, while 408 more had them “often”. Another 762 “sometimes” orgasmed while 243 had them rarely or never. Such figures are similar to those for western countries.
There were of course, several factors involved in such differences but, said Pollet, money was one of the main ones.
He said: “Increasing partner income had a highly positive effect on women’s self-reported frequency of orgasm. More desirable mates cause women to experience more orgasms.”
This is not an effect limited to Chinese women. Previous research in Germany and America has looked at attributes such as body symmetry and attractiveness, finding that these are also linked with orgasm frequency. Money, however, seems even more important.
David Buss, professor of psychology at the University of Texas, Austin, who raised this question in his book The Evolution of Desire believes female orgasms have several possible purposes.
“They could promote emotional bonding with a high-quality male or they could serve as a signal that women are highly sexually satisfied, and hence unlikely to seek sex with other men,” he said. “What those orgasms are saying is ‘I'm extremely loyal, so you should invest in me and my children’."
Source:
TIMESONLINE
Monday, January 19, 2009
Martin Luther King Jr. Day
I Have a Dream: MLK Day in New York City
Walking in New York City on Martin Luther King, Jr. Day 2008, we asked friends and strangers to participate in a project to provoke thought about the words of this famous speech. On its 45th anniversary, Dr. King's message of hope rings as relevant today as it did in 1963.
I love love his speech and the happiest moment and history has been made.
Walking in New York City on Martin Luther King, Jr. Day 2008, we asked friends and strangers to participate in a project to provoke thought about the words of this famous speech. On its 45th anniversary, Dr. King's message of hope rings as relevant today as it did in 1963.
I love love his speech and the happiest moment and history has been made.
Monday, January 5, 2009
The President-elect's Message on World AIDS Day
President-elect Barack Obama took some time on World AIDS Day to remember the history of the AIDS epidemic and to thank all those who work so hard to stop this epidemic and educate the public.
Friday, January 2, 2009
MySpace Comments
I wish you Health...
I wish you Love of friends and family...
And Peace within your heart.
I wish you the Beauty of nature...
I wish you Wisdom to choose priorities...
I wish you Generousity so you may share...
I wish you Happiness and Joy...
And Blessings for the New Year.
I wish you the best of everything...
That you so well deserve.
Sweet/Abesha Care
Tuesday, December 30, 2008
Monday, December 8, 2008
Monday, December 1, 2008
WORLD AIDS DAY DECEMBER 1
December 1, 2008 marks the 20th anniversary of World AIDS DAY. The day is also an apportunity to highlight the need for continued development of education and prevention initiavtives.
STOP AIDS, KEEP THE PROMISE!!
ENJOY LIFE, TAKE CONTROL. STOP HIV/AIDS
WORLD AIDS DAY QUIZ
THE WHITE HOUSE/ WORLD AIDS DAY, 2008
So today is a good day to decide to get smart.
Make sure your children understand the risks — in 2004, the CDC estimated that more than 5 percent of new HIV infections are found in young people.
Make appointments for HIV testing for your child who is sexually active and for yourself and your partner if you're in a new relationship — or a longer term one in which neither has been tested.
KNOW HOW HIV TRANSMITTED
WHO MESSAGE FOR WORLD AIDS DAY
CONTROL YOUR LIFE
GLOBAL VOICES/ WORLD AIDS DAY: BLOGGING POSITIVELY
IMPORTANT HIV/AIDS AWARENESS DAYS
KEEP YOUR BODY HEALTHY
WORLD AIDS DAY-BE CONCERNED
DONATE TO OUR "CHILDREN AFFECTED BY HIV/AIDS
Show Others You Support the Room By Joining The groupe of Abesha Care at Paltalk.
To share ideas and meet Habesha people living HIV/AIDS visit www.abeshacare.com Love connection site.
Wednesday, November 12, 2008
Vote For CNN Heroes Ato Yohannes Gebregeorgis
Ethiopia Reads' Founder Yohannes Gebregeorgis is A CNN Hero! Story Available Online Now.
www.cnn.com/heroes and Please vote for him!
Please visit his site for more information
http://www.ethiopiareads.org/
Monday, November 10, 2008
Friday, October 24, 2008
Watch the Video "HIV/AIDS AWARENESS in ETHIOPIA"
HIV/AIDS AWARENESS in ETHIOPIA: Approaches to Prevention (2006)
WHOSE CHILDREN ARE THEY NOW? AIDS Orphans in Ethiopia (Amharic version) (2006)
From RISK to ACTION: Women and HIV/AIDS in Ethiopia (Amharic version) (2006)
WHOSE CHILDREN ARE THEY NOW? AIDS Orphans in Ethiopia (Amharic version) (2006)
From RISK to ACTION: Women and HIV/AIDS in Ethiopia (Amharic version) (2006)
Friday, October 17, 2008
Subscribe to:
Posts (Atom)
